page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Hydroxychloroquine (Plaquenil)

Category:

  • Antimalarial

Description:

  • 4- aminoquinoline

Indications:

  • Malaria prophylaxis

  • Malaria treatment

  • Lupus Erythematosus and Rheumatoid Arthritis

Contraindications:

  • Retinal or visual field changes of any etiology

Precautions:

  • Pregnancy category C

  • Take with food or milk to decrease gastrointestinal side effects.

  • Report signs of “chinconism” (tinnitis, headache, nausea, vision changes)

  • Dosages expressed in form of Hydroxychloroquine base:

    • Hydroxychloroquine Sulfate 200mg = Hydroxychloroquine base 60mg

Adverse Reactions (Side Effects):

  • Gastrointestinal: nausea, vomiting, anorexia, stomach pain

  • Chinconism

  • Muscle pain

  • Rash  

Dosage:

  • Administered orally

  • Dosages listed in Hydroxychloroquine base strength (HB)

  • Malaria prophylaxis:

    • Begin treatment 1-2 weeks prior, during and 4 weeks post travel to endemic area

    • Administer dose on same day every week

    • Adult: 310mg HB once every week

    • Child: (dosed per age or weight (5mg HB per kg)

      • < 1 year old: 37.5mg HB

      • 1-3 years old: 75mg HB

      • 4-6 years old: 100mg HB

      • 7-10 years old: 150mg HB

      • 11-16 years old: 225mg HB

  • Malaria treatment:

    • Initial dose:

      • Adult: 620mg CB

      • Child: 10mg/kg

    • Second dose (6 hours later)

      • Adult: 310mg CB

      • Child: 5mg/kg CB

    • Doses days 2 & 3:

      • Adult: 310mg CB

      • Child: 5mg/kg CB

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site